Other languages Edwards Lifesciences Corporation Sao Paulo

Equities

E1WL34

BRE1WLBDR000

Market Closed - Sao Paulo Other stock markets 03:33:07 2024-07-16 pm EDT			5-day change	1st Jan Change
119.3 ^BRL	-2.41%		-5.89%	+28.18%

Jul. 16	Truist Raises Price Target on Edwards Lifesciences to $110 From $105, Maintains Buy Rating	MT
Jul. 15	Sector Update: Health Care Stocks Edge Lower Late Afternoon	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Edge Lower Late Afternoon	Jul. 15
Sector Update: Health Care Stocks Retreat Monday Afternoon	Jul. 15
Sector Update: Health	Jul. 15
Top Midday Stories: Trump Media & Technology Group Shares Rise After Ex-President Trump Survives Assassination Attempt; Goldman Sachs, BlackRock Q2 Earnings Gain; Edwards Lifesciences to Acquire Innovalve Bio Medical	Jul. 15
Edwards Lifesciences to Acquire Innovalve Bio Medical	Jul. 15
Edwards Lifesciences Secures Health Canada's Approval for PASCAL Precision Transcatheter Valve Repair System	Jul. 12
Affluent Medical, Edwards Lifesciences Sign EUR15 Million Deals for Mitral Valve Technology	Jul. 12
Affluent : le titre grimpe après les accords avec Edwards	Jul. 12
Affluent Medical : bondit après son contrat de 15 millions d'euros avec Edwards Lifesciences	Jul. 12
Edwards Lifesciences Corporation Appoints David T. Feinberg to the Board of Directors and as a Member of the Audit Committee of the Board	Jul. 10
Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	Jun. 20
Edwards Lifesciences Corporation Announces Executive Changes	Jun. 17
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	Jun. 05
Sector Update: Health Care Stocks Steady Premarket Monday	Jun. 03
Edwards Lifesciences : Autodesk, Gamestop, Nvidia... les valeurs à suivre aujourd'hui à Wall Street -	Jun. 03
Edwards Lifesciences : cède sa filiale soins intensifs à Becton Dickison	Jun. 03
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	Jun. 03
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	Jun. 03
EE.UU. - Valores a seguir en Wall Street (actualizado)	May. 31
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	May. 13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT